Through a series of strategic acquisitions,CR Sanjiu successfully expanded into antifungal, antitumor and anti-infection treatments.In 2023, CR Sanjiu achieved revenues of 24.74 billion yuan,with 39 ...
China's top court solved a long-term intellectual property case between two technological companies on Wednesday, coinciding with Constitution Day, demonstrating the country's judicial determination a ...